view.info.amerisourcebergen.com
Open in
urlscan Pro
13.111.91.54
Public Scan
URL:
https://view.info.amerisourcebergen.com/?qs=04657337f8bcf123dd64c63de51191a09aba8da916a801200cfc871dacdbe3e06651c8f8fda42d4debceca119135...
Submission: On September 14 via api from US — Scanned from DE
Submission: On September 14 via api from US — Scanned from DE
Form analysis
0 forms found in the DOMText Content
View manufacturer, indication, class of trade information and product information. Additional information found in Prescribing Information. View this email as a web page September 14, 2022 New product from AmerisourceBergen specialty distribution Your AmerisourceBergen specialty distributor is now authorized for the product(s) below. This notification of product availability is being sent to all active customers. Class of trade restrictions may apply. The product(s) below can be ordered today through ABC Order or your preferred ordering method. ABC Order is our convenient, 24/7 online platform designed to simplify your ordering process. Click here to learn more or request access. Skyrizi® Manufactured by Abbvie, SKYRIZI (risankizumab-rzaa) is an interleukin-23 antagonist that is now indicated for the treatment of moderately to severely active Crohn's disease in adults. To learn more about Skyrizi, see U.S. Full Prescribing Information. Skyrizi can be distributed to all classes of trade with the exception of wholesaler/distributors and research centers. Please note that Skyrizi 600 mg is available via dropship from the manufacturer only. If you're interested in learning more about Skyrizi, click the button below and a member of our team will be in touch soon. Contact me about ordering Skyrizi AB item # Product Size NDC # 15960086 Skyrizi 600 mg/10 mL SDV 00074-5015-01 SotyktuTM Manufactured by Bristol Myers-Squibb, SOTYKTU (deucravacitinib) is a tyrosine kinase 2 (TYK2) inhibitor indicated for the treatment of adults with moderate-to-severe plaque psoriasis who are candidates for systemic therapy or phototherapy. To learn more about Sotyktu, see U.S. Full Prescribing Information. Sotyktu can be distributed to the following classes of trade: * Closed door pharmacies * Hospitals (inpatient and outpatient) * Infusion clinics/centers * Office-based physicians * Oncology clinics * Specialty pharmacies * VA/DoD facilities If you're interested in learning more about Sotyktu, click the button below and a member of our team will be in touch soon. Contact me about ordering Sotyktu AB item # Product Size NDC # 10272120 Sotyktu 6 mg/30 tabs 00003-0895-11 Spevigo® Manufactured by Boehringer Ingelheim, SPEVIGO (spesolimab-sbzo) is an interleukin-36 receptor antagonist indicated for the treatment of generalized pustular psoriasis flares in adults. To learn more about Spevigo, see U.S. Full Prescribing Information. Spevigo can be distributed to the following classes of trade: * 340B-covered entities excluding contract pharmacies * Government entities that purchase off the FSS contract * Inpatient hospitals * Physician offices * All clinics including infusion, non-infusion, hospital-owned and physician-owned All other classes of trade must obtain written approval from Boehringer Ingelheim. If you're interested in learning more about Spevigo, click the button below and a member of our team will be in touch soon. Contact me about ordering Spevigo AB item # Product Size NDC # 10271813 Spevigo 450 mg/2 × 7.5 mL SDV 00597-0035-10 SD-100881 click This email was sent to annadelia.scheible@memorialhermann.org because you have an account with or are a valued partner of AmerisourceBergen. If you no longer wish to receive these types of emails, please click here to unsubscribe or update your email preferences. Update Profile AmerisourceBergen - 1 West First Avenue Conshohocken, PA 19428 © 2022 AmerisourceBergen. All Rights Reserved. x